Merrimack Pharmaceuticals, Inc (MACK) Covered Calls

Merrimack Pharmaceuticals, Inc covered calls Merrimack Pharmaceuticals Inc is a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer.

You can sell covered calls on Merrimack Pharmaceuticals, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MACK (prices last updated Fri 4:16 PM ET):

Merrimack Pharmaceuticals, Inc (MACK) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
4.08 +0.07 3.91 4.40 50K - 0.0B
Covered Calls For Merrimack Pharmaceuticals, Inc (MACK)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Dec 21 4 0.00 4.40 -9.1% -415.2%
Jan 18 4 0.30 4.10 -2.4% -24.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Merrimack Pharmaceuticals, Inc. engages in discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer. It applies a systems biology-based approach to biomedical research, throughout the research and development process. Merrimack Pharmaceuticals was founded by Anthony J. Sinskey, Gavin MacBeath and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.